Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 2/20 | 0.81 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.81 |
| ▸ | NPC1 | O15118 | 2/20 | 0.81 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.67 |
| ▸ | HPGD | P15428 | 3/20 | 0.67 |
| ▸ | HTT | P42858 | 2/20 | 0.65 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.61 |
| ▸ | TSHR | P16473 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | MEN1 | O00255 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | ALPL | P05186 | 1/20 | 0.59 |
| ▸ | ALPI | P09923 | 1/20 | 0.59 |
| ▸ | ALPG | P10696 | 1/20 | 0.59 |
| ▸ | USP2 | O75604 | 1/20 | 0.58 |
| ▸ | POLB | P06746 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17921354 | 0.86 | RAB9A (0.63) | RAB9ASMN1; SMN2NPC1KMT2AHPGD | |
| SCHEMBL10475269 | 0.86 | RECQL (0.71) | RAB9ASMN1; SMN2NPC1KMT2AHPGD | |
| SCHEMBL19002729 | 0.84 | RAB9A (0.69) | RAB9ASMN1; SMN2NPC1KMT2AHPGD | |
| SCHEMBL13673100 | 0.84 | RAB9A (0.69) | RAB9ASMN1; SMN2NPC1HPGDHTT | |
| SCHEMBL11775788 | 0.83 | KMT2A (0.69) | RAB9ASMN1; SMN2NPC1KMT2AHPGD | |
| SCHEMBL4860148 | 0.83 | RECQL (0.81) | RAB9ASMN1; SMN2NPC1KMT2AHPGD | |
| SCHEMBL19002731 | 0.82 | RAB9A (0.67) | RAB9ASMN1; SMN2NPC1KMT2AHPGD | |
| SCHEMBL4053405 | 0.82 | RAB9A (0.67) | RAB9ASMN1; SMN2NPC1HPGDHTT | |
| SCHEMBL7748285 | 0.82 | HPGD (0.63) | RAB9ASMN1; SMN2NPC1KMT2AHPGD | |
| SCHEMBL27754995 | 0.82 | RAB9A (0.67) | RAB9ASMN1; SMN2NPC1KMT2AHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-108291171-B | Synergistic lubricating oil composition containing mixture of olefin copolymer dispersant type viscosity improver and amine compound | 雪佛龙奥伦耐有限责任公司 | 2022-02-01 | — | — | CN | disclosed |
| EP-3405554-B1 | LUBRICATING OIL COMPOSITION CONTAINING A MIXTURE OF OLEFIN COPOLYMER DISPERSANT-TYPE VISCOSITY IMPROVER AND AMINE COMPOUND | CHEVRON ORONITE CO (US) | 2019-12-25 | — | — | EP | disclosed |
| US-10414999-B2 | Synergistic lubricating oil composition containing a mixture of olefin copolymer dispersant-type viscosity improver and amine compound | CHEVRON ORONITE COMPANY LLC (US) | 2019-09-17 | — | — | US | disclosed |
| EP-3405554-A1 | SYNERGISTIC LUBRICATING OIL COMPOSITION CONTAINING A MIXTURE OF OLEFIN COPOLYMER DISPERSANT-TYPE VISCOSITY IMPROVER AND AMINE COMPOUND | Chevron Oronite Company LLC (US) | 2018-11-28 | — | — | EP | disclosed |
| EP-2875105-B1 | VISCOSITY IMPROVER GRAFTED WITH UNSATURATED ACYLATING AGENT AND AN ARYLOXYALYLKENE MONOAMINE | CHEVRON ORONITE CO (US) | 2018-01-03 | — | — | EP | disclosed |
| US-20170231962-A1 | Compound Combinations for Attenuation of Bacterial Virulence | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2017-08-17 | — | — | US | disclosed |
| WO-2017127637-A1 | SYNERGISTIC LUBRICATING OIL COMPOSITION CONTAINING A MIXTURE OF OLEFIN COPOLYMER DISPERSANT-TYPE VISCOSITY IMPROVER AND AMINE COMPOUND | CHEVRON ORONITE COMPANY LLC (US) | 2017-07-27 | — | — | WO | disclosed |
| US-20170211011-A1 | SYNERGISTIC LUBRICATING OIL COMPOSITION CONTAINING A MIXTURE OF OLEFIN COPOLYMER DISPERSANT-TYPE VISCOSITY IMPROVER AND AMINE COMPOUND | CHEVRON ORONITE COMPANY LLC | 2017-07-27 | — | — | US | disclosed |
| US-9115237-B2 | Viscosity improver grafted with unsaturated acylating agent and an aryloxyalylkene monoamine | CHEVRON ORONITE COMPANY LLC (US) | 2015-08-25 | — | — | US | disclosed |
| EP-2875105-A1 | VISCOSITY IMPROVER GRAFTED WITH UNSATURATED ACYLATING AGENT AND AN ARYLOXYALYLKENE MONOAMINE | Chevron Oronite Company LLC (US) | 2015-05-27 | — | — | EP | disclosed |
| US-8841306-B2 | Antimicrobials | PANACEA BIOTEC LTD. (IN) | 2014-09-23 | — | — | US | disclosed |
| WO-2014014561-A1 | VISCOSITY IMPROVER GRAFTED WITH UNSATURATED ACYLATING AGENT AND AN ARYLOXYALYLKENE MONOAMINE | CHEVRON ORONITE COMPANY LLC (US) | 2014-01-23 | — | — | WO | disclosed |
| US-20140024567-A1 | VISCOSITY IMPROVER GRAFTED WITH UNSATURATED ACYLATING AGENT AND AN ARYLOXYALYLKENE MONOAMINE | CHEVRON ORONITE COMPANY LLC (US) | 2014-01-23 | — | — | US | disclosed |
| US-8268885-B2 | Entry inhibitors of the HIV virus | JANSSEN R&D IRELAND (IE) | 2012-09-18 | — | — | US | disclosed |
| US-8268885-B2 | Entry inhibitors of the HIV virus | JANSSEN R&D IRELAND (IE) | 2012-09-18 | — | — | US | disclosed |
| EP-2300430-A1 | BENZENE OR THIOPHENE DERIVATIVE AND USE THEREOF AS VAP-1 INHIBITOR | R-Tech Ueno, Ltd. (JP) | 2011-03-30 | — | — | EP | disclosed |
| WO-2010058423-A2 | NOVEL ANTIMICROBIALS | PANACEA BIOTEC LTD. (IN) | 2010-05-27 | — | — | WO | disclosed |
| US-5276192-A | Preparation of phenoxyethanamines | TEXACO CHEMICAL COMPANY (US) | 1994-01-04 | — | — | US | disclosed |
| CN-1034918-A | Chemical compound | ICI PLC (GB) | 1989-08-23 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170231962-A1 | Compound Combinations for Attenuation of Bacterial Virulence | PNISR, PGLS, QRFPR | RAB9A 127/4885SMN1; SMN2 4813/4885NPC1 4739/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.